Log In
BCIQ
Print this Print this
 

SL-301

  Manage Alerts
Collapse Summary General Information
Company Stemline Therapeutics Inc.
DescriptionSmall molecule gamma-secretase inhibitor that inhibits NOTCH pathway
Molecular Target Notch 1 (NOTCH1)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today